An appeal by Novartis AG from a ruling in a patent infringement suit filed by MedImmune in Germany over the sale of Lucentis is pending, Novartis disclosed in its January…
Oral argument on an appeal by Medtronic Inc. from a ruling in a patent litigation between Medtronic CoreValve LLC, Edwards Lifesciences, Inc. and Corevalve, Inc. has been scheduled for January…
Metronic Inc. is indemnified for the claims made by Wyeth and Cordis Corporation in a patent infringement suit filed against the Company and its subsidiary, Medtronic disclosed in its December…
Mirowski Family Ventures, LLC’s appeal from a non-infringement ruling in its patent litigation with Medtronic Inc. remains pending, Medtronic disclosed in its December 7, 2011, Form 10-Q filing with the…
A patent infringement suit filed by Merck & Co. Inc. against Teva Parenteral Medicines, Inc. relating to Cancidas is ongoing, Merck disclosed in its August 8, 2011, Form 10-Q filing…
A patent infringement suit filed by Merck & Co. Inc. against Apotex Corp. relating to Nasonex is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with the…
A patent infringement suit filed by Merck & Co. Inc. against Hamni USA, Inc. relating to Nexium is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with…
Patent litigation between Teva and Amgen Inc. has been dismissed, the Company disclosed in its August 8, 2011 Form 10-Q filing with the U.S. Securities and Exchange Commission for the…
A patent infringement suit filed by Merck & Co. Inc. against Lupin Ltd. relating to Nexium is ongoing with no trial dates presently scheduled, Merck disclosed in its August 8,…
A two-count declaratory judgment action for non-infringement of U.S. Patent Nos. 6,916,941 and 7,420,069, which are listed in the U.S. Food and Drug Administration’s Orange Book for Lexapro, filed by…